RANK Pathway Inhibition Sensitizes Triple-Negative Breast Cancer to CDK4/6 Inhibitors and Enhances Immune Response

This is a publication. If there is no link to the publication on this page, you can try the pre-formated search via the search engines listed on this page.

Authors: Inês Gomes, Maria Martelo, Rúben D. Vilela, María Jiménez, Eva M. Trinidad, Jorge Gómez-Miragaya, Eva González-Suárez, Érica Martins, Sofia S. Torres, Patrícia Corredeira, Joana L. Miranda, André Mansinho, Sofia Torres, Catarina Abreu, Rita Sousa, Sandra Casimiro, Luís Costa

Journal title: Molecular Cancer Therapeutics

Journal publisher: American Association for Cancer Research

Published year: 2025

Published pages: OF1-OF13

DOI identifier: 10.1158/1535-7163.mct-24-1158

ISSN: 1535-7163